Compliance SweepBack to stories →
← Back to stories
Governance & business operationsNew in this edition

FDA lists a Class I recall of four lots of the Edwards Commander M mitral valve delivery system over a manufacturing issue that may cause balloon rupture

The U.S. Food and Drug Administration's (FDA) Enforcement Report for the week of November 11, 2026 lists a Class I recall by Edwards Lifesciences, LLC of the Edwards Commander M Delivery System, model 9880CM29A, a delivery system for a percutaneously delivered mitral valve prosthesis. The recall covers lot numbers 67718561, 67804014, 67887043 and 67887044. The reason given is a manufacturing issue which may result in cardiovascular balloon rupturing.

Who this affects

Hospitals with structural heart or cardiac catheterization programs that stock the Edwards Commander M Delivery System, model 9880CM29A, and their supply chain and risk management teams.

Why it matters

Inference: hospitals holding the listed lots should set them aside until the firm's instructions are confirmed. The firm's customer notice and its instructions were not retrieved, so the steps below are recommended practice, not the firm's stated instructions.

Implementation playbook

  1. Search cath lab and structural heart inventory for model 9880CM29A, lots 67718561, 67804014, 67887043 and 67887044, and quarantine any found. Owner: Cardiovascular Services and Supply Chain. Due: 2026-11-18.
  2. Ask Edwards Lifesciences whether a customer notice was sent, follow its return or replacement instructions, and document the response. Owner: Supply Chain. Due: 2026-11-25.
  3. Review any balloon rupture during a procedure with these lots and report it to MedWatch. Owner: Risk Management. Due: 2026-11-30.

Scope and timing

Authority status
Recall classification
Responsible owner
Cardiovascular Services; Supply Chain; Risk Management
Other dates
2026-11-11: FDA Enforcement Report for the week of November 11, 2026; 2026-11-02: posted internet date of the record

Not established

The firm's customer notice, recall initiation date, quantity and distribution were not retrieved. Whether FDA posted a separate recall notice page was not checked.

Sources

Complete edition and supplemental material

This article in the complete report →

Executive triage, source-coverage limitations, context and forward horizons remain in the complete report.

Read the entire Compliance Sweep report →

← Return to stories

Privacy preferences

Where enabled for this site, Cloudflare Web Analytics can send page-use and performance measurements to Cloudflare. This panel provides information and does not turn analytics on or off.

This panel stores no tracking choice and does not change your tool saves, screening, resets, reports or exports. Other sites have separate settings.

Read Privacy & Cookies